2 Result(s)

Article

Total genomic alteration as measured by SNP-array-based molecular karyoty** is predictive of overall survival in a cohort of MDS or AML patients treated with azacitidine

Metaphase cytogenetics (MC) has a major role in the risk stratification of patients with myelodysplastic syndromes (MDSs) and can affect the choice of therapies. Azacitidine (AZA) has changed the outcome of pa...

T Cluzeau, C Moreilhon, N Mounier, J-M Karsenti, L Gastaud… in Blood Cancer Journal (2013)